Arjo AB (publ) (ARJO-B) - Total Assets
Based on the latest financial reports, Arjo AB (publ) (ARJO-B) holds total assets worth Skr14.98 Billion SEK (≈ $1.61 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See ARJO-B net assets for net asset value and shareholders' equity analysis.
Arjo AB (publ) - Total Assets Trend (2013–2025)
This chart illustrates how Arjo AB (publ)'s total assets have evolved over time, based on quarterly financial data.
Arjo AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2025)
Arjo AB (publ)'s total assets of Skr14.98 Billion consist of 28.1% current assets and 71.9% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 5.6% |
| Accounts Receivable | Skr2.19 Billion | 14.6% |
| Inventory | Skr1.18 Billion | 7.9% |
| Property, Plant & Equipment | Skr2.70 Billion | 18.0% |
| Intangible Assets | Skr7.21 Billion | 48.2% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Arjo AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Arjo AB (publ) (ARJO-B) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Arjo AB (publ)'s current assets represent 28.1% of total assets in 2025, a decrease from 42.6% in 2013.
- Cash Position: Cash and equivalents constituted 5.6% of total assets in 2025, down from 7.7% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 42.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 48.2% of total assets.
Arjo AB (publ) Competitors by Total Assets
Key competitors of Arjo AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
Arjo AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.78 | 1.07 | 0.69 |
| Quick Ratio | 1.28 | 0.76 | 0.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr1.84 Billion | Skr312.00 Million | Skr-1.76 Billion |
Arjo AB (publ) - Advanced Valuation Insights
This section examines the relationship between Arjo AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.99 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -8.0% |
| Total Assets | Skr14.98 Billion |
| Market Capitalization | $662.98 Million USD |
Valuation Analysis
Below Book Valuation: The market values Arjo AB (publ)'s assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Arjo AB (publ)'s assets decreased by 8.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Arjo AB (publ) (2013–2025)
The table below shows the annual total assets of Arjo AB (publ) from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr14.98 Billion ≈ $1.61 Billion |
-7.98% |
| 2024-12-31 | Skr16.28 Billion ≈ $1.75 Billion |
+1.71% |
| 2023-12-31 | Skr16.00 Billion ≈ $1.72 Billion |
-1.01% |
| 2022-12-31 | Skr16.17 Billion ≈ $1.74 Billion |
+10.64% |
| 2021-12-31 | Skr14.61 Billion ≈ $1.57 Billion |
+5.44% |
| 2020-12-31 | Skr13.86 Billion ≈ $1.49 Billion |
-3.91% |
| 2019-12-31 | Skr14.42 Billion ≈ $1.55 Billion |
+9.79% |
| 2018-12-31 | Skr13.14 Billion ≈ $1.41 Billion |
+7.58% |
| 2017-12-31 | Skr12.21 Billion ≈ $1.31 Billion |
-17.01% |
| 2016-12-31 | Skr14.71 Billion ≈ $1.58 Billion |
+4.97% |
| 2015-12-31 | Skr14.02 Billion ≈ $1.51 Billion |
-5.43% |
| 2014-12-31 | Skr14.82 Billion ≈ $1.60 Billion |
+12.12% |
| 2013-12-31 | Skr13.22 Billion ≈ $1.42 Billion |
-- |
About Arjo AB (publ)
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and pr… Read more